A quick peek into the report
Table of Contents
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion Criteria
1.1.3 Exclusion Criteria
1.1.4 Overview
1.1.4.1 Market Size and Growth Potential
2.1 Key Trends
2.1.1 Rising Number of Startups in the Market
2.1.2 Increased Awareness Regarding Preventative Measures and Personalized Treatment
2.1.3 Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
2.2 Opportunity Assessment
2.3 Regulatory Framework
2.3.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
2.3.2 Regulatory Framework in Japan
2.3.3 Regulatory Framework in China
2.4 Patent Analysis
2.4.1 Awaited Technological Developments
2.4.1.1 Patent Analysis (by Country)
2.4.1.2 Patent Analysis (by Year)
2.5 Business Models
2.6 Case Studies
2.6.1 Case Study 1: Ultromics Limited
2.6.1.1 The EchoGo System
2.6.1.1.1 Developement
2.6.1.1.2 Use Case and Reliability
2.6.1.2 A Success Story
2.6.1.3 Partners and Recognitions
2.6.2 Case Study 2: CorVista Health, Inc.
2.6.2.1 The CorVista System
2.6.2.2 A Success Story
2.7 Ongoing Clinical Trials
2.8 Funding Scenario
2.9 End User Perception
2.10 Entry Barriers for New Entrants
3.1 Impact on the Overall Market
3.2 Pre-COVID-19 Scenario
3.3 During COVID-19 Scenario
3.4 Post COVID-19 Scenario
4.1 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
4.1.1 Key Findings and Opportunity Assessment
4.1.2 Digital Adoption
4.1.3 Market Dynamics
4.1.3.1 Impact Analysis
4.1.4 Market Sizing and Forecast
4.1.4.1 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.2 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.2.1 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.3 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.4 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country)
4.1.4.5.1 Japan
4.1.4.5.1.1 Market Dynamics
4.1.4.5.1.2 Market Size and Forecast
4.1.4.5.1.2.1 Japan Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.1.2.2 Japan Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.1.2.2.1 Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics) 84
4.1.4.5.1.2.3 Japan Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.1.2.4 Japan Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.2 China
4.1.4.5.2.1 Market Dynamics
4.1.4.5.2.2 Market Size and Forecast
4.1.4.5.2.2.1 China Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.2.2.2 China Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.2.2.2.1 China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.2.2.3 China Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.2.2.4 China Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.3 India
4.1.4.5.3.1 Market Dynamics
4.1.4.5.3.2 Market Size and Forecast
4.1.4.5.3.2.1 India Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.3.2.2 India Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.3.2.2.1 India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.3.2.3 India Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.3.2.4 India Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.4 Australia
4.1.4.5.4.1 Market Dynamics
4.1.4.5.4.2 Market Size and Forecast
4.1.4.5.4.2.1 Australia Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.4.2.2 Australia Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.4.2.2.1 Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.4.2.3 Australia Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.4.2.4 Australia Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.5 South Korea
4.1.4.5.5.1 Market Dynamics
4.1.4.5.5.2 Market Size and Forecast
4.1.4.5.5.2.1 South Korea Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.5.2.2 South Korea Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.5.2.2.1 South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.5.2.3 South Korea Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.5.2.4 South Korea Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.6 Rest-of-Asia-Pacific
4.1.4.5.6.1 Market Size and Forecast
4.1.4.5.6.1.1 Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.6.1.2 Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.6.1.2.1 Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.6.1.3 Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.6.1.4 Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
5.1 Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
5.2 Key Strategies and Developments
5.2.1 Regulatory and Legal Activities
5.3 Company Profiles
5.3.1 Canon Inc.
5.3.1.1 Company Overview
5.3.1.2 Role of Canon Inc. in the Cardiac AI Monitoring and Diagnostics Market
5.3.1.3 Financials
5.3.1.4 Analyst Perception
5.3.2 Sample Company
5.3.2.1 Overview
5.3.2.2 Top Products / Product Portfolio
5.3.2.3 Top Competitors
5.3.2.4 Target Customers
5.3.2.5 Key Personnel
5.3.2.6 Analyst View
5.3.2.7 Market Share
5.3.3 Sample Company
5.3.3.1 Overview
5.3.3.2 Top Products / Product Portfolio
5.3.3.3 Top Competitors
5.3.3.4 Target Customers
5.3.3.5 Key Personnel
5.3.3.6 Analyst View
5.3.3.7 Market Share
5.3.4 Sample Company
5.3.4.1 Overview
5.3.4.2 Top Products / Product Portfolio
5.3.4.3 Top Competitors
5.3.4.4 Target Customers
5.3.4.5 Key Personnel
5.3.4.6 Analyst View
5.3.4.7 Market Share
5.3.5 Sample Company
5.3.5.1 Overview
5.3.5.2 Top Products / Product Portfolio
5.3.5.3 Top Competitors
5.3.5.4 Target Customers
5.3.5.5 Key Personnel
5.3.5.6 Analyst View
5.3.5.7 Market Share
5.3.6 Sample Company
5.3.6.1 Overview
5.3.6.2 Top Products / Product Portfolio
5.3.6.3 Top Competitors
5.3.6.4 Target Customers
5.3.6.5 Key Personnel
5.3.6.6 Analyst View
5.3.6.7 Market Share
5.3.7 Sample Company
5.3.7.1 Overview
5.3.7.2 Top Products / Product Portfolio
5.3.7.3 Top Competitors
5.3.7.4 Target Customers
5.3.7.5 Key Personnel
5.3.7.6 Analyst View
5.3.7.7 Market Share
5.3.8 Sample Company
5.3.8.1 Overview
5.3.8.2 Top Products / Product Portfolio
5.3.8.3 Top Competitors
5.3.8.4 Target Customers
5.3.8.5 Key Personnel
5.3.8.6 Analyst View
5.3.8.7 Market Share
Table 1: Regulatory Framework
Table 2: Key Questions Answered in the Report
Table 3: Startups Entering the Market
Table 4: Regulatory Framework of Different Countries
Table 5: Cardiac AI Monitoring and Diagnostics Market, Awaited Technological Developments
Table 6: CorVista Health Inc. Publications
Table 7: Cardiac AI Monitoring and Diagnostics Market, Ongoing Clinical Trials
Table 8: Investments and Fundings in Cardiac AI Monitoring and Diagnostics Market
Table 9: Applications of Artificial Intelligence in Cardiology During COVID-19 Pandemic
Table 10: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 11: Total Deaths and CVD Death Rates of Men/Women in 2018 in Japan (Per 100,000 of the Population)
Table 12: Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
Figure 1: AI in Cardiac Monitoring and Diagnosis
Figure 2: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 3: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Market Dynamics
Figure 4: Key Trends in the Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
Figure 5: Entry Barriers for New Entrants
Figure 6: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Product), 2022 and 2032
Figure 7: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Type), 2022 and 2032
Figure 8: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Application), 2022 and 2032
Figure 9: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by End Users), 2022 and 2032
Figure 10: Key Developments and Strategies Analysis, January 2020-June 2023
Figure 11: Cardiac AI Monitoring and Diagnostics Market: Research Methodology
Figure 12: Primary Research Methodology
Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
Figure 14: Top-Down Approach (Segment-Wise Analysis)
Figure 15: Overview of the Role of AI in Cardiology
Figure 16: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Size and Growth Potential, $Million, 2022-2032
Figure 17: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Key Trends
Figure 18: Potential of AI for Processing Patient's Own Data
Figure 19: Advantages of AI-Enabled Wearable Sensors for Cardiac Monitoring
Figure 20: Cardiac AI Monitoring and Diagnostics Market, Key Trends, Opportunity Assessment, 2023-2032
Figure 21: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Country), January 2018-June 2023
Figure 22: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Year), January 2018-June 2023
Figure 23: Different Types of Business Models in the AI in Healthcare Scenario
Figure 24: Subscription-Based Model the Market is Shifting Towards
Figure 25: Partners of Ultromics Limited
Figure 26: Ultromics Limited:Awards and Recognitions
Figure 27: The CorVista System
Figure 28: Cardiac AI Monitoring and Diagnostics Market, Quarterly Analysis of Funding Scenario, January 2020-June 2023
Figure 29: Cardiac AI Monitoring and Diagnostics Market, End User Perceptions
Figure 30: Entry Barriers for New Entrants
Figure 31: Recommendations to Tackle the Entry Barriers
Figure 32: Tools and Technologies of AI for Cardiology During COVID-19
Figure 33: Cardiac AI Monitoring and Diagnostics Market Share (by Region), 2022-2032
Figure 34: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
Figure 35: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 36: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 37: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 38: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 39: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 40: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 41: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
Figure 42: Japan Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 43: Japan Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 44: Japan Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 45: Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 46: Japan Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 47: Japan Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 48: China Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 49: China Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 50: China Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 51: China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 52: China Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 53: China Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 54: India Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 55: India Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 56: India Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 57: India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 58: India Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 59: India Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 60: Australia Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 61: Australia Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 62: Australia Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 63: Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 64: Australia Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 65: Australia Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 66: South Korea Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 67: South Korea Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 68: South Korea Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 69: South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 70: South Korea Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 71: South Korea Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 72: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 73: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 74: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 75: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 76: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 77: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 78: Share of Key Developments and Strategies, January 2019-June 2023
Figure 79: Regulatory and Legal Activities (by Company), January 2019-June 2023
Figure 80: Canon Inc.: Overall Product Portfolio
Figure 81: Canon Inc.: Overall Financials, $Million, 2020-2022
Figure 82: Canon Inc.: Net Revenue (by Segment), $Million, 2020-2021
Figure 83: Canon Inc.: Net Revenue (by Segment), $Million, 2022
Figure 84: Canon Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 85: Canon Inc.: R&D Expenditure, $Million, 2020-2022
How can this report add value to the Organization ?
Product/Innovation Strategy: The APAC cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Report Coverage
|
Asia-Pacific Cardiac AI Monitoring and Diagnostics Market |
|||
|
Base Year |
2022 |
Market Size in 2023 |
$xxx Billion |
|
Forecast Period |
2023-2032 |
Value Projection and Estimation by 2033 |
$xxx Billion |
|
CAGR During Forecast Period |
xxx % |
|
|
Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Overview
Introduction to Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
The Asia-Pacific cardiac AI monitoring and diagnostics market was valued at $200.4 million in 2023 and is anticipated to reach $2,154.6 million by 2032, witnessing a CAGR of 30.20% during the forecast period 2023-2032. Growth in the cardiac AI monitoring and diagnostics market is driven by widespread cardiovascular diseases, government support for AI in healthcare, increasing cardiology-focused AI research, more regulatory approvals for AI cardiac devices, and advances in AI cardiac diagnostics technology.
Market Introduction
The Asia-Pacific (APAC) market for cardiac AI monitoring and diagnostics is witnessing significant growth, driven by several key factors. The region faces a high burden of cardiovascular diseases, fueled by aging populations and increasing prevalence of lifestyle-related risk factors like diabetes and hypertension. This has heightened the demand for advanced diagnostic and monitoring tools. Governments across APAC are increasingly recognizing the potential of AI in healthcare, leading to supportive policies and investments in AI technology. Additionally, the region is seeing a surge in healthcare technology research, including AI applications in cardiology, making advanced diagnostics more accessible and efficient. Furthermore, the increasing number of regulatory approvals for AI-based cardiac diagnostic devices reflects a growing trust in their effectiveness and safety. Technological advancements in AI are enhancing the precision and accuracy of cardiac diagnostics, catering to the region's diverse and expanding healthcare needs.
Market Segmentation:
Segmentation 1: by Product
• Software
• Hardware
Segmentation 2: by Type
• Cardiac Diagnostics
o Imaging
o ECG-Based
o Others
• Cardiac Monitoring
Segmentation 3: by Application
• Ischemic Heart Disease/CAD
• Cardiac Arrhythmias
• Ischemic Stroke
• Others
Segmentation 4: by End User
• Hospitals
• Diagnostic Centers
• Other End Users
Segmentation 5: by Country
• China
• Japan
• India
• Australia
• South Korea
• Rest-of-Asia-Pacific
Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
Analysis and Forecast
Frequently Asked Questions
The companies developing AI-enabled solutions for the diagnosis and monitoring of cardiac disease or the companies looking to leverage such technology in the field of cardiology should buy this report.
The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022 and is anticipated to reach $10,666.5 million by 2032, witnessing a CAGR of 26.88% during the forecast period 2023-2032.
AI is used in cardiac monitoring to analyze electrocardiogram (ECG) data for abnormalities and trends. Machine learning algorithms can detect irregular heart rhythms, predict cardiac events, and offer real-time alerts to healthcare providers. AI enhances the accuracy and efficiency of diagnosis, enabling timely intervention and improved patient care in cardiac health management.
AI-based cardiac monitoring and diagnostics can detect a wide range of conditions, including but not limited to atrial fibrillation, bradycardia, tachycardia, and other arrhythmias. It can also identify changes in heart rate variability, which may indicate stress, fatigue, or other health-related factors. Additionally, AI can play a crucial role in the early detection of Ischemic Heart Disease (IHD) or Coronary Artery Disease (CAD) and Ischemic Stroke, helping healthcare professionals intervene promptly and improve patient outcomes.
AI can assist in chronic cardiac condition management by continuously monitoring patients, providing real-time alerts for potential issues, and optimizing treatment plans based on individual patient data. This proactive approach helps patients better manage their conditions and reduces the risk of complications.